These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22097731)

  • 21. Advanced glycation end products as an upstream molecule triggers ROS-induced sFlt-1 production in extravillous trophoblasts: a novel bridge between oxidative stress and preeclampsia.
    Huang QT; Zhang M; Zhong M; Yu YH; Liang WZ; Hang LL; Gao YF; Huang LP; Wang ZJ
    Placenta; 2013 Dec; 34(12):1177-82. PubMed ID: 24144948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective effects of gliclazide on high glucose and AGEs-induced damage of glomerular mesangial cells and renal tubular epithelial cells via inhibiting RAGE-p22phox-NF-kB pathway.
    Yang PY; Li PC; Feng B
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):9099-9107. PubMed ID: 31696501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Irbesartan inhibits advanced glycation end product (AGE)-induced up-regulation of vascular cell adhesion molecule-1 (VCAM-1) mRNA levels in glomerular endothelial cells.
    Matsui T; Nishino Y; Maeda S; Takeuchi M; Yamagishi S
    Microvasc Res; 2011 May; 81(3):269-73. PubMed ID: 21236267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of Advanced Glycation End Products (AGEs) Accumulation by Pyridoxamine Modulates Glomerular and Mesangial Cell Estrogen Receptor α Expression in Aged Female Mice.
    Pereira-Simon S; Rubio GA; Xia X; Cai W; Choi R; Striker GE; Elliot SJ
    PLoS One; 2016; 11(7):e0159666. PubMed ID: 27428057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ribozyme targeting of receptor for advanced glycation end products in mouse mesangial cells.
    Tsuji H; Iehara N; Masegi T; Imura M; Ohkawa J; Arai H; Ishii K; Kita T; Doi T
    Biochem Biophys Res Commun; 1998 Apr; 245(2):583-8. PubMed ID: 9571198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The receptor for advanced glycation end products is highly expressed in the skin and upregulated by advanced glycation end products and tumor necrosis factor-alpha.
    Lohwasser C; Neureiter D; Weigle B; Kirchner T; Schuppan D
    J Invest Dermatol; 2006 Feb; 126(2):291-9. PubMed ID: 16374460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of oxidative stress in advanced glycation end product-induced mesangial cell activation.
    Lal MA; Brismar H; Eklöf AC; Aperia A
    Kidney Int; 2002 Jun; 61(6):2006-14. PubMed ID: 12028441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advanced glycation end products induce production of reactive oxygen species via the activation of NADPH oxidase in murine hepatic stellate cells.
    Guimarães EL; Empsen C; Geerts A; van Grunsven LA
    J Hepatol; 2010 Mar; 52(3):389-97. PubMed ID: 20133001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blockade by phosphorothioate aptamers of advanced glycation end products-induced damage in cultured pericytes and endothelial cells.
    Higashimoto Y; Matsui T; Nishino Y; Taira J; Inoue H; Takeuchi M; Yamagishi S
    Microvasc Res; 2013 Nov; 90():64-70. PubMed ID: 24012635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sodium-glucose cotransporter 2-mediated oxidative stress augments advanced glycation end products-induced tubular cell apoptosis.
    Maeda S; Matsui T; Takeuchi M; Yamagishi S
    Diabetes Metab Res Rev; 2013 Jul; 29(5):406-12. PubMed ID: 23508966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AGEs activate mesangial TGF-beta-Smad signaling via an angiotensin II type I receptor interaction.
    Fukami K; Ueda S; Yamagishi S; Kato S; Inagaki Y; Takeuchi M; Motomiya Y; Bucala R; Iida S; Tamaki K; Imaizumi T; Cooper ME; Okuda S
    Kidney Int; 2004 Dec; 66(6):2137-47. PubMed ID: 15569303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Olmesartan blocks inflammatory reactions in endothelial cells evoked by advanced glycation end products by suppressing generation of reactive oxygen species.
    Yamagishi S; Matsui T; Nakamura K; Inoue H; Takeuchi M; Ueda S; Okuda S; Imaizumi T
    Ophthalmic Res; 2008; 40(1):10-5. PubMed ID: 18025836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Irbesartan inhibits advanced glycation end product-induced increase in asymmetric dimethylarginine level in mesangial cells through its anti-oxidative properties.
    Ishibashi Y; Matsui T; Ueda S; Fukami K; Okuda S; Yamagishi S
    Int J Cardiol; 2014 Oct; 176(3):1120-2. PubMed ID: 25156845
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of advanced glycosylation end products and rosiglitazone on the expression and secretion of galectin-3 in human renal mesangial cells.
    Sun ZL; Ma CJ; Jin H; Yuan Y; Liu NF
    Chin Med J (Engl); 2009 May; 122(9):1067-71. PubMed ID: 19493442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Binding of receptor for advanced glycation end products (RAGE) ligands is not sufficient to induce inflammatory signals: lack of activity of endotoxin-free albumin-derived advanced glycation end products.
    Valencia JV; Mone M; Koehne C; Rediske J; Hughes TE
    Diabetologia; 2004 May; 47(5):844-52. PubMed ID: 15127201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of reactive oxygen species and cell survival in the presence of advanced glycation end products and similar structures.
    Schmitt A; Bigl K; Meiners I; Schmitt J
    Biochim Biophys Acta; 2006 Sep; 1763(9):927-36. PubMed ID: 16942810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Extract of Ginkgo biloba and alpha-lipoic acid attenuate advanced glycation end products accumulation and RAGE expression in diabetic nephropathy rats].
    Li XZ; Yan HD; Wang J
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Apr; 31(4):525-31. PubMed ID: 21608227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advanced glycation end products-induced apoptosis attenuated by PPARdelta activation and epigallocatechin gallate through NF-kappaB pathway in human embryonic kidney cells and human mesangial cells.
    Liang YJ; Jian JH; Liu YC; Juang SJ; Shyu KG; Lai LP; Wang BW; Leu JG
    Diabetes Metab Res Rev; 2010 Jul; 26(5):406-16. PubMed ID: 20583309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metformin inhibits advanced glycation end products (AGEs)-induced renal tubular cell injury by suppressing reactive oxygen species generation via reducing receptor for AGEs (RAGE) expression.
    Ishibashi Y; Matsui T; Takeuchi M; Yamagishi S
    Horm Metab Res; 2012 Nov; 44(12):891-5. PubMed ID: 22864903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advanced glycation end products induce oxidative stress and mitochondrial dysfunction in SH-SY5Y cells.
    Wang X; Yu S; Wang CY; Wang Y; Liu HX; Cui Y; Zhang LD
    In Vitro Cell Dev Biol Anim; 2015 Feb; 51(2):204-9. PubMed ID: 25381033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.